IRAK3 and neoplasm: Interleukin-1 receptor-associated kinase 3 (IRAK3) is the major pathway involved in recurrence in younger patients, while Wnt10b-related genes is the major pathway associated with recurrence in older patients with tumor-positive SLNs.